Search

Your search keyword '"Johnson & Johnson -- Officials and employees"' showing total 2,436 results
Start Over Descriptor "Johnson & Johnson -- Officials and employees"
2,436 results on '"Johnson & Johnson -- Officials and employees"'

201. L3Harris: Michelle Turner Named CFO

Subjects
Johnson & Johnson -- Officials and employees, Pharmaceutical industry -- Officials and employees, Arts and entertainment industries
Abstract

L3Harris Technologies reported it has named Michelle Turner as Senior Vice President and Chief Financial Officer (CFO), reporting to Vice Chair and Chief Executive Officer Christopher E. Kubasik, effective immediately. [...]

Published
2022

202. L3Harris Names Michelle Turner as Senior VP and CFO

Subjects
Johnson & Johnson -- Officials and employees, Pharmaceutical industry -- Officials and employees, Arts and entertainment industries
Abstract

L3Harris Technologies has named Michelle Turner as Senior Vice President and Chief Financial Officer (CFO), reporting to Vice Chair and Chief Executive Officer Christopher E. Kubasik, effective immediately. According to [...]

Published
2022

203. Duato named chairman at J&J

Subjects
Johnson & Johnson -- Officials and employees, Chairpersons -- Appointments, resignations and dismissals, Pharmaceutical industry -- Officials and employees, Business, regional
Abstract

Byline: Jessica Perry Johnson & Johnson CEO Joaquin Duato started off 2022 stepping into that role, and in 2023, he'll again begin a new year with new responsibilities. Alex Gorsky [...]

Published
2022

204. Royal Society of NSW celebrates 200 years

Subjects
Johnson & Johnson -- Officials and employees, Trade and professional associations -- Rites, ceremonies and celebrations, Pharmaceutical industry -- Officials and employees
Abstract

The origins of The Royal Society of NSW can be traced to 1821. It is a forum for the expression and transmission of ideas. It exists to advance knowledge and [...]

Published
2022

205. Lynx Biosciences: Sylvaine Cases Named Chief Business Officer

Subjects
Johnson & Johnson -- Officials and employees, Pharmaceutical industry -- Officials and employees, Arts and entertainment industries
Abstract

Lynx Biosciences reported the appointment of Sylvaine Cases, Ph.D., as the company's first Chief Business Officer (CBO). According to a media release, Dr. Cases joins LynxBio from Johnson & Johnson, [...]

Published
2021

206. APEC CEO Summit USA 2023 To Convene World Leaders and Business Executives to Discuss Creating Economic Opportunity

Subjects
Merck & Company Inc. -- Officials and employees, FedEx Corp. -- Officials and employees, General Motors Co. -- Officials and employees, Johnson & Johnson -- Officials and employees, QUALCOMM Inc. -- Officials and employees, Boeing Co. -- Officials and employees, MasterCard International Inc. -- Officials and employees, Microsoft Corp. -- Officials and employees, Exxon Mobil Corp. -- Officials and employees, Credit and debit card industry -- Officials and employees, Computer software industry -- Officials and employees, Automobile industry -- Officials and employees, Semiconductor industry -- Officials and employees, Aircraft industry -- Officials and employees, Courier services -- Officials and employees, Petroleum industry -- Officials and employees, Chief executive officers, Entrepreneurship, Businesspeople, Pharmaceutical industry -- Officials and employees, Semiconductor industry, Automobile Industry, Banking, finance and accounting industries, Asia-Pacific Economic Cooperation -- Officials and employees
Abstract

(PRWeb) - The United States will host the Asia-Pacific Economic Cooperation (APEC) CEO Summit convening more than 1,000 business executives and welcoming key world leaders from across the Asia-Pacific at [...]

Published
2023

207. APEC CEO Summit USA 2023 To Convene World Leaders and Business Executives to Discuss Creating Economic Opportunity

Subjects
Merck & Company Inc. -- Officials and employees, FedEx Corp. -- Officials and employees, General Motors Co. -- Officials and employees, Johnson & Johnson -- Officials and employees, QUALCOMM Inc. -- Officials and employees, Boeing Co. -- Officials and employees, MasterCard International Inc. -- Officials and employees, Microsoft Corp. -- Officials and employees, Exxon Mobil Corp. -- Officials and employees, Credit and debit card industry -- Officials and employees, Computer software industry -- Officials and employees, Automobile industry -- Officials and employees, Semiconductor industry -- Officials and employees, Aircraft industry -- Officials and employees, Courier services -- Officials and employees, Petroleum industry -- Officials and employees, Chief executive officers, Entrepreneurship, Businesspeople, Pharmaceutical industry -- Officials and employees, Semiconductor industry, Automobile Industry, Business, News, opinion and commentary, Asia-Pacific Economic Cooperation -- Officials and employees
Abstract

The Asia-Pacific's premier business forum will take place November 15-16 at San Francisco's Moscone Center, sessions will address sustainability, inclusion, resilience and innovation. SEATTLE, May 27, 2023 /PRNewswire-PRWeb/ -- The [...]

Published
2023

208. RUBICON BAKERS HIRE SEB SIETHOFF AS CEO

Subjects
Unilever N.V. -- Officials and employees, Johnson & Johnson -- Officials and employees, Ball Corp. -- Officials and employees, Container industry -- Officials and employees, Food industry -- Officials and employees, Chief executive officers, Pharmaceutical industry -- Officials and employees, Food and beverage production/distribution software, General interest, News, opinion and commentary
Abstract

RICHMOND: Rubicon Bakers has issued the following news release: Rubicon Bakers ('Rubicon' or the 'Company') is pleased to announce the hiring of Sebastian 'Seb' Siethoff as Chief Executive Officer. Mr. [...]

Published
2023

209. Vir Biotechnology Appoints Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer

Subjects
Johnson & Johnson -- Officials and employees, Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

SAN FRANCISCO: Vir Biotechnology, Inc. has issued the following news release: Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Jeff Calcagno, M.D., as Executive Vice President and Chief [...]

Published
2023

210. Vir Biotechnology Appoints Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer

Subjects
Johnson & Johnson -- Officials and employees, Pharmaceutical industry -- Officials and employees, Banking, finance and accounting industries, Business
Abstract

SAN FRANCISCO, May 15, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer. Dr. [...]

Published
2023

211. Nyxoah Appoints Christoph Eigenmann as a Chief Commercial Officer

Subjects
Euronext Brussels S.A./N.V. -- Officials and employees, Johnson & Johnson -- Officials and employees, High technology industry, Securities industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Securities industry, General interest, News, opinion and commentary
Abstract

Mont-Saint-Guibert: Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ('Nyxoah' or the 'Company'), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today [...]

Published
2023

212. Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer

Subjects
Euronext Brussels S.A./N.V. -- Officials and employees, Johnson & Johnson -- Officials and employees, High technology industry, Sleep apnea syndromes, Securities industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Securities industry, Banking, finance and accounting industries, Business
Abstract

Nyxoah Appoints Christoph Eig enmann as Chief Commercial Officer Mont-Saint-Guibert, Belgium - Ma y 1 0 , 202 3 , 10 : 05 p m CET / 4 :05 p [...]

Published
2023

213. Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer

Subjects
Euronext Brussels S.A./N.V. -- Officials and employees, Johnson & Johnson -- Officials and employees, High technology industry, Sleep apnea syndromes, Business, international
Abstract

(GLOBE NEWSWIRE via COMTEX) -- Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer Mont-Saint-Guibert, Belgium - May 10, 2023, 10:05pm CET / 4:05pm ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) [...]

Published
2023

214. Florida Food Products appoints Kevin Neat as CFO

Subjects
Johnson & Johnson -- Officials and employees, Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

LAKE MARY: Florida Food Products, LLC (FFP), one of the world's largest independent providers of natural ingredients, announced that Kevin Neat, former Chief Financial Officer of Johnson & Johnson's North [...]

Published
2023

215. Florida Food Products Names Kevin Neat Chief Financial Officer

Subjects
Johnson & Johnson -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, Business, international
Abstract

Seasoned Finance Executive Brings Extensive Business Leadership Experience to FFP LAKE MARY, Fla. -- Florida Food Products, LLC ('FFP' or the 'Company'), one of the world's largest independent providers of [...]

Published
2023

216. FORM 8-K: JOHNSON & JOHNSON Files Current Report (May 01, 2023)

Subjects
Johnson & Johnson -- Officials and employees, Securities law -- Reports, Stock-exchange -- Reports, Securities industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Securities industry, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: JOHNSON & JOHNSON, has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on May 01, 2023: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 [...]

Published
2023

217. Florida Food Products Names Kevin Neat Chief Financial Officer

Subjects
Johnson & Johnson -- Officials and employees, Pharmaceutical industry -- Officials and employees, News, opinion and commentary
Abstract

LAKE MARY, Fla.--(BUSINESS WIRE)--May 5, 2023-- Florida Food Products, LLC (“FFP” or the “Company”), one of the world’s largest independent providers of natural ingredients, today announced that Kevin Neat, former [...]

Published
2023

218. Official Committee Representing Talc-Related Cancer Victims Files Motion to Dismiss

Subjects
United States. Bankruptcy Court. District of New Jersey -- Officials and employees, Johnson & Johnson -- Officials and employees, Bankruptcy law, Bankruptcy, Pharmaceutical industry -- Officials and employees, Company bankruptcy, General interest, News, opinion and commentary
Abstract

NEW YORK: The Official Committee of Talc Claimants filed a motion to dismiss the second bankruptcy petition of LTL Management. The TCC urges the U.S. Bankruptcy Court for the District [...]

Published
2023

219. Committee Representing Talc-Related Cancer Victims Files Motion to Dismiss

Subjects
United States. Bankruptcy Court. District of New Jersey -- Officials and employees, Johnson & Johnson -- Officials and employees, Debtor and creditor, Bankruptcy law, Bankruptcy, Pharmaceutical industry -- Officials and employees, Company bankruptcy, Business, News, opinion and commentary
Abstract

The Official Committee of the Talc Claimants dispute LTL's second bad-faith bankruptcy filing emphasizing LTL's attempts to manufacture financial distress NEW YORK, April 24, 2023 /PRNewswire/ -- Today, the Official [...]

Published
2023

220. FORM 8-K: JOHNSON & JOHNSON Files Current Report (Apr 03, 2023)

Subjects
United States. Securities and Exchange Commission -- Officials and employees, Johnson & Johnson -- Officials and employees, Securities law -- Reports, Stock-exchange -- Reports, Financial statements -- Reports, Securities industry -- Officials and employees, Securities industry, News, opinion and commentary, Securities Exchange Act
Abstract

Washington: JOHNSON & JOHNSON, has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Apr 03, 2023: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 [...]

Published
2023

221. Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors

Subjects
Johnson & Johnson -- Officials and employees, Eli Lilly and Co. -- Officials and employees, Boards of directors -- Appointments, resignations and dismissals, Pharmaceutical industry -- Officials and employees, Banking, finance and accounting industries, Business
Abstract

- Seasoned Psychiatrist and Global Pharmaceutical R&D Executive with Over Two Decades of Experience in Clinical Development, Including at Eli Lilly, Johnson & Johnson, Bristol Myers Squibb and Sunovion Pharmaceuticals [...]

Published
2023

222. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions

Subjects
Johnson & Johnson -- Officials and employees, Executives, Chief operating officers, Chief financial officers, Venture capital companies -- Officials and employees, Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

CAMBRIDGE: Flare Therapeutics has issued the following press release: Flare Therapeutics Inc., a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, today announced the [...]

Published
2023

223. STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer

Subjects
Johnson & Johnson -- Officials and employees, STAAR Surgical Co. -- Officials and employees, Eyewear industry -- Officials and employees, Chief operating officers, Pharmaceutical industry -- Officials and employees, Business, Business, international
Abstract

New Positions Demonstrate Increased Commitment and Focus on Continued Industry Leading Growth LAKE FOREST, Calif. -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses [...]

Published
2023

224. CXL Ophthalmics Appointed Tiffany Haynes as Vice President of Clinical Operations

Subjects
Johnson & Johnson -- Officials and employees, Executives, Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

SHERBORN: CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today announced that Tiffany Haynes has been appointed as Vice President of Clinical Operations. With more than [...]

Published
2023

225. Two Industry Veterans Join Acuitive Technologies, Inc. Board of Directors as Independent Members

Subjects
Johnson & Johnson -- Officials and employees, Corporate directors, Chairpersons, Boards of directors, Pharmaceutical industry -- Officials and employees, Banking, finance and accounting industries, Business
Abstract

ALLENDALE, N.J., March 13, 2023 (GLOBE NEWSWIRE) -- Acuitive Technologies announced that Vince Forlenza and Gary Fischetti will join their Board of Directors. Both bring decades of medical technology experience [...]

Published
2023

226. Rapport Therapeutics Launches with $100 Million to Transform the Treatment of Neurological Disease through the Discovery and Development of Precision Therapies

Subjects
Venture Partners -- Officials and employees, Johnson & Johnson -- Officials and employees, Nervous system diseases -- Care and treatment, Proteins, Venture capital companies -- Officials and employees, Pharmaceutical industry -- Officials and employees, General interest, News, opinion and commentary
Abstract

BOSTON: RAPPORT THERAPEUTICS, INC has issued the following news release: Rapport Therapeutics, Inc., a clinical-stage biotechnology company dedicated to the discovery and development of precision medicines for neurological disorders, launched [...]

Published
2023

227. Venatorx Pharmaceuticals Appoints Tomas J. Heyman as Non-Executive Chairman

Subjects
Johnson & Johnson -- Officials and employees, Therapeutics Inc. -- Officials and employees, Bacterial infections, Chairpersons, Pharmaceutical industry -- Officials and employees, Business, Business, international
Abstract

Dr. Michael Diem Steps Down from Board of Directors MALVERN, Pa. -- Venatorx Pharmaceuticals, a private, clinical-stage pharmaceutical company focused on improving health outcomes for patients with difficult-to-treat drug resistant [...]

Published
2023

228. Rapport Therapeutics Launches with $100 Million to Transform the Treatment of Neurological Disease through the Discovery and Development of Precision Therapies

Subjects
Venture Partners -- Officials and employees, Johnson & Johnson -- Officials and employees, Neural circuitry, Nervous system diseases -- Care and treatment, Proteins, Venture capital companies -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, Business, international
Abstract

- Series A financing led by Third Rock Ventures with participation from ARCH Venture Partners and Johnson & Johnson Innovation-JJDC, Inc. (JJDC) - Novel platform targets specific neural circuits leveraging [...]

Published
2023

229. Canadian Biotech's Approach to Growing C-Level Talent

Author

Dutton, Gail

Subjects
Johnson & Johnson -- Officials and employees, Pfizer Canada Inc. -- Officials and employees, Novo Nordisk A/S -- Officials and employees, Biotechnology, Intellectual property, Biotechnology industries -- Officials and employees, Pharmaceutical industry -- Officials and employees, Intellectual property, Business, general, Business, Education, Human resources and labor relations
Abstract

The adMare Executive Institute aims to grow C-level talent for the Canadian biopharmaceutical sector. Here's how this 10-month program works, and the results it is generating. The Canadian biotech industry [...]

Published
2020

230. Beckley Psytech appoints Frank Wiegand as Chief Medical Officer

Subjects
Johnson & Johnson -- Officials and employees, Nervous system diseases, Pharmaceutical industry -- Officials and employees, Pharmaceuticals and cosmetics industries
Abstract

Beckley Psytech, a privately owned clinical stage, biotechnology company dedicated to addressing neuropsychiatric disorders through the novel application of psychedelic medicines, has announced the appointment of Frank Wiegand MD. PhD. [...]

Published
2021

231. Better Therapeutics names Thiago Licias de Oliveira as Its Chief People Officer

Subjects
Johnson & Johnson -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, News, opinion and commentary
Abstract

Better Therapeutics announced the appointment of Thiago Licias de Oliveira as its Chief People Officer. In this newly created role, Thiago will develop and implement a people strategy to build, [...]

Published
2021

232. Johnson & Johnson chief scientific officer Paul Stoffels to retire

Subjects
Johnson & Johnson -- Officials and employees, Business, News, opinion and commentary
Abstract

Johnson & Johnson announced that Paul Stoffels, currently vice chairman of the executive committee and chief scientific officer of Johnson & Johnson, will retire from the company effective December [...]

Published
2021

233. Photocure appoints Anders Neijber as Vice President, Global Medical Affairs and Clinical Development

Subjects
Johnson & Johnson -- Officials and employees, Pfizer Inc. -- Officials and employees, AstraZeneca PLC -- Officials and employees, Executives -- Appointments, resignations and dismissals, Pharmaceutical industry -- Officials and employees, Health
Abstract

2021 SEP 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announced the appointment of [...]

Published
2021

234. Shake Shack, Marriott, and other top companies are facing a painful labor shortage. Here's what executives are saying about the problem

Subjects
Shake Shack -- Officials and employees, Johnson & Johnson -- Officials and employees, Publicly held corporations, Executives, Restaurant industry -- Officials and employees, Vaccines, Pharmaceutical industry -- Officials and employees, Consumer news and advice, General interest
Abstract

Many US companies are struggling to hire workers due to a widespread labor shortage. Shake Shack, Marriott, Johnson & Johnson executives have all noted hiring challenges recently. Nurses are quitting [...]

Published
2021

235. Johnson & Johnson to acquire Abiomed for $16.6

Subjects
Johnson & Johnson -- Officials and employees, Abiomed Inc. -- Officials and employees, High technology industry, Business, regional
Abstract

Byline: Dawn Furnas Johnson & Johnson announced Nov. 1 that it entered into a definitive agreement to acquire medical technology company Abiomed for approximately $16.6 billion. According to the announcement [...]

Published
2022

236. Johnson & Johnson unveils new company name

Subjects
Johnson & Johnson -- Officials and employees, Business, regional
Abstract

Byline: Dawn Furnas It's well documented that Johnson & Johnson will split into two companies, a major announcement that was made in November 2021. Since then, the planned entities have [...]

Published
2022

237. Q1 2022 Emergent BioSolutions Inc Earnings Call - Final

Subjects
Johnson & Johnson -- Officials and employees, Public relations agencies -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, Narcan (Medication)
Abstract

Presentation OPERATOR: Good day and thank you for standing by. Welcome to the First Quarter 2022 Emergent BioSolutions Earnings Conference Call. (Operator Instructions) I would now like to hand the [...]

Published
2022

238. Biosig Technologies Inc at Noble Capital Markets Investor Conference (Virtual) - Final

Subjects
Johnson & Johnson -- Officials and employees, Financial markets, Heart beat, Pharmaceutical industry -- Officials and employees, Business
Abstract

Presentation KENNETH LONDONER, FOUNDER, CEO, CHAIRMAN & DIRECTOR, BIOSIG TECHNOLOGIES, INC.: So BioSig is a NASDAQ company. We trade under the ticker symbol BSGM. We've been on the NASDAQ since [...]

Published
2022

239. Wellesley College president Paula A. Johnson is named to Johnson & Johnson board

Author

Wenger, Barbara

Subjects
Johnson & Johnson -- Officials and employees, Medical policy, College presidents, Chairpersons, Pharmaceutical industry -- Officials and employees, Human resources and labor relations, Law, Wellesley College -- Officials and employees
Abstract

Johnson & Johnson announced the appointment of Paula A. Johnson, M.D., president of Wellesley College, to its board. 'I am excited to welcome Dr. Paula Johnson to Johnson & Johnson's [...]

Published
2023

240. Neurocrine Biosciences names new director

Subjects
Johnson & Johnson -- Officials and employees, Neurocrine Biosciences Inc. -- Officials and employees, Corporate directors, Business schools, Biotechnology industry -- Officials and employees, Health care industry -- Officials and employees, Chairpersons, Pharmaceutical industry -- Officials and employees, Health care industry, Chemistry
Abstract

M2 PHARMA-July 12, 2023-Neurocrine Biosciences names new director (C)2023 M2 COMMUNICATIONS Neurocrine Biosciences Inc (Nasdaq: NBIX), a California-based neuroscience-focused, biopharmaceutical company, announced on Tuesday that it has named Christine A [...]

Published
2023

241. Neurocrine Biosciences names new director

Subjects
Johnson & Johnson -- Officials and employees, Neurocrine Biosciences Inc. -- Officials and employees, Corporate directors, Business schools, Biotechnology industry -- Officials and employees, Health care industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Health care industry, Business
Abstract

M2 EQUITYBITES-July 12, 2023-Neurocrine Biosciences names new director (C)2023 M2 COMMUNICATIONS http://www.m2.co.uk Neurocrine Biosciences Inc (Nasdaq: NBIX), a California-based neuroscience-focused, biopharmaceutical company, announced on Tuesday that it has named Christine [...]

Published
2023

242. Appia Bio Expands Leadership Team With Sylvaine Cases, Ph.D. Appointed Chief Business Officer and Alex Babayan, Ph.D. as Vice President, Head of Regulatory Affairs

Subjects
Johnson & Johnson -- Officials and employees, Sanofi S.A. -- Officials and employees, Biotechnology industry -- Officials and employees, Biomedical engineering, Pharmaceutical industry -- Officials and employees, Biotechnology industry, Health, Science and technology
Abstract

2023 JUL 10 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Appia Bio, Inc., a biotechnology company developing allogeneic chimeric antigen receptor (CAR)-engineered invariant [...]

Published
2023

243. Grossman Named President and Chief Medical Officer at Coya Therapeutics

Subjects
Johnson & Johnson -- Officials and employees, Eli Lilly and Co. -- Officials and employees, Pharmaceutical industry -- Officials and employees, Chemistry
Abstract

M2 PHARMA-July 6, 2023-Grossman Named President and Chief Medical Officer at Coya Therapeutics (C)2023 M2 COMMUNICATIONS - US-based clinical-stage biotechnology company Coya Therapeutics, Inc. (NASDAQ: COYA), which is developing biologics [...]

Published
2023

244. Why experts think life will get better by 2023 - if enough people get vaccinated

Subjects
Johnson & Johnson -- Officials and employees, Pfizer Inc. -- Officials and employees, Drug approval, Coronaviruses, Pharmaceutical industry -- Officials and employees, Consumer news and advice, General interest
Abstract

Hello, Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and I'm catching up after taking some time off to hike the (https://twitter.com/lydiaramsey125/status/1430876547729149953) Grand Canyon from rim to rim. This week [...]

Published
2021

245. Johnson & Johnson names Joaquin Duato as new CEO effective January 3rd

Subjects
Johnson & Johnson -- Officials and employees, Chairpersons -- Appointments, resignations and dismissals, Pharmaceutical industry -- Officials and employees, Business, News, opinion and commentary
Abstract

Johnson & Johnson announced that Mr. Alex Gorsky, currently Chairman and CEO, will serve as Executive Chairman of Johnson & Johnson and transition the CEO role to Mr. Joaquin Duato, [...]

Published
2021

246. Becton Dickinson announces Christopher DelOrefice as CFO

Subjects
Becton, Dickinson and Co. -- Officials and employees, Johnson & Johnson -- Officials and employees, Medical test kit industry -- Officials and employees, Medical equipment and supplies industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Business, News, opinion and commentary
Abstract

Becton Dickinson (BDX) announced that Christopher DelOrefice has been named executive vice president and chief financial officer, or CFO, effective September 6. DelOrefice succeeds Christopher Reidy, who announced his intent [...]

Published
2021

247. Zume Adds 2 Execs to Its Team

Subjects
Unilever N.V. -- Officials and employees, Johnson & Johnson -- Officials and employees, Procter & Gamble Co. -- Officials and employees, Executives, Food industry -- Officials and employees, Soap and cleaning agents industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Food and beverage production/distribution software, Arts and entertainment industries
Abstract

Zume reported the hiring of two new executives focused on scaling up operations both internally and externally. According to a media release, biographies of the executives are as follows: Pamela [...]

Published
2021

248. BlueTriton Brands Appoints Jorge Mesquita as CEO

Subjects
Johnson & Johnson -- Officials and employees, Procter & Gamble Co. -- Officials and employees, Chief executive officers -- Appointments, resignations and dismissals, Soap and cleaning agents industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Arts and entertainment industries
Abstract

BlueTriton Brands rrr has named Jorge Mesquita as Chief Executive Officer. According to a media release, the veteran Johnson & Johnson and Procter & Gamble executive joins as the Company, [...]

Published
2021

249. BlueTriton Brands Names Jorge Mesquita as CEO

Subjects
Johnson & Johnson -- Officials and employees, Procter & Gamble Co. -- Officials and employees, Soap and cleaning agents industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Food and beverage industries
Abstract

BlueTriton Brands rrr has named Jorge Mesquita as Chief Executive Officer. According to a media release, the veteran Johnson & Johnson and Procter & Gamble executive joins as the Company, [...]

Published
2021

250. BlueTriton Brands Names Jorge Mesquita as CEO

Subjects
Johnson & Johnson -- Officials and employees, Procter & Gamble Co. -- Officials and employees, Soap and cleaning agents industry -- Officials and employees, Pharmaceutical industry -- Officials and employees, Arts and entertainment industries
Abstract

BlueTriton Brands has named Jorge Mesquita as Chief Executive Officer. According to a media release, the veteran Johnson & Johnson and Procter & Gamble executive joins as the Company, known [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results